Basilea

Basilea Pharmaceutica is one of few biopharmaceutical companies in the world focused on the research, development and commercialization of targeted oncology small molecules and new antibiotics and antifungals.

The Basel-based company, listed since 2004 (SIX:BSLN) has successfully brought to market 2 anti-infective brands: Cresemba® (isavuconazole), for the treatment of invasive fungal infections and Zevtera®, an antibiotic for the treatment of severe hospital bacterial infections.